NTP TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF METHYL ISOBUTYL KETONE (CAS NO. 108-10-1) IN F344/N RATS AND B6C3F1 MICE (INHALATION STUDIES) NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 February 2007 NTP TR 538 NIH Publication No 07-4476 National Institutes of Health Public Health Service U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES FOREWORD The National Toxicology Program (NTP) is an interagency program within the Public Health Service (PHS) of the Department of Health and Human Services (HHS) and is headquartered at the National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH). Three agencies contribute resources to the program: NIEHS/NIH, the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention (NIOSH/CDC), and the National Center for Toxicological Research of the Food and Drug Administration (NCTR/FDA). Established in 1978, the NTP is charged with coordinating toxicological testing activities, strengthening the science base in toxicology, developing and validating improved testing methods, and providing information about potentially toxic substances to health regulatory and research agencies, scientific and medical communities, and the public. The Technical Report series began in 1976 with carcinogenesis studies conducted by the National Cancer Institute. In 1981, this bioassay program was transferred to the NTP. The studies described in the Technical Report series are designed and conducted to characterize and evaluate the toxicologic potential, including carcinogenic activity, of selected substances in laboratory animals (usually two species, rats and mice). Substances selected for NTP toxicity and carcinogenicity studies are chosen primarily on the basis of human exposure, level of production, and chemical structure. The interpretive conclusions presented in NTP Technical Reports are based only on the results of these NTP studies. Extrapolation of these results to other species, including characterization of hazards and risks to humans, requires analyses beyond the intent of these reports. Selection per se is not an indicator of a substance’s carcinogenic potential. The NTP conducts its studies in compliance with its laboratory health and safety guidelines and FDA Good Laboratory Practice Regulations and must meet or exceed all applicable federal, state, and local health and safety regulations. Animal care and use are in accordance with the Public Health Service Policy on Humane Care and Use of Animals. Studies are subjected to retrospective quality assurance audits before being presented for public review. NTP Technical Reports are indexed in the NIH/NLM PubMed database and are available free of charge electronically on the NTP website (http://ntp.niehs.nih.gov) or in hardcopy upon request from the NTP Central Data Management group at [email protected] or (919) 541-3419. NTP TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF METHYL ISOBUTYL KETONE (CAS NO. 108-10-1) IN F344/N RATS AND B6C3F1 MICE (INHALATION STUDIES) NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 February 2007 NTP TR 538 NIH Publication No 07-4476 National Institutes of Health Public Health Service U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES 2 CONTRIBUTORS National Toxicology Program NTP Pathology Working Group Evaluated and interpreted results and reported findings Evaluated slides and prepared pathology report on rats (January 8, 2004) F.A. Suarez, M.D., M.S., Study Scientist M.A. Hanes, D.V.M., Chairperson R.A. Herbert, D.V.M., Ph.D., Study Pathologist Integrated Laboratory Systems R.S. Chhabra, Ph.D. K.J. Cimon, D.V.M., M.S. D.W. Bristol, Ph.D. Experimental Pathology Laboratories, Inc. J.R. Bucher, Ph.D. S.A. Elmore, D.V.M., Observer G.E. Kissling, Ph.D. National Toxicology Program D.E. Malarkey, D.V.M, Ph.D. R.A. Herbert, D.V.M., Ph.D. R.R. Maronpot, D.V.M. National Toxicology Program S.D. Peddada, Ph.D. G.D. Hill, D.V.M., Ph.D. J.H. Roycroft, Ph.D. National Toxicology Program C.S. Smith, Ph.D. Y.B. Kim, D.V.M., Ph.D., Observer National Toxicology Program G.S. Travlos, D.V.M. J.F. Mann, D.V.M., M.S., Observer K.L. Witt, M.S. Southern Research Institute R.A. Miller, D.V.M., Ph.D. Battelle Northwest Operations Experimental Pathology Laboratories, Inc. Conducted studies and evaluated pathology findings G. Pearse, B.V.M.&S. National Toxicology Program J.A. Dill, Ph.D., Principal Investigator J.C. Peckham, D.V.M., M.S., Ph.D. S.L. Grumbein, D.V.M., Ph.D. Experimental Pathology Laboratories, Inc. B.K. Hayden H. Satoh, D.V.M., Ph.D., Observer R.A. Renne, D.V.M. National Toxicology Program J.C. Seely, D.V.M. Experimental Pathology Laboratories, Inc. Experimental Pathology Laboratories, Inc. Provided pathology review Evaluated slides and prepared pathology report on mice (November 6, 2003) M.H. Hamlin, II, D.V.M., Principal Investigator A.E. Brix, D.V.M. A.W. Suttie, B.V.Sc., Ph.D., Chairperson K.J. Cimon, D.V.M., M.S. Integrated Laboratory Systems R.A. Miller, D.V.M., Ph.D. A.E. Brix, D.V.M., Ph.D. J.C. Peckham, D.V.M., M.S., Ph.D. Experimental Pathology Laboratories, Inc. J.C. Seely, D.V.M. M.F. Cesta, D.V.M., Observer National Toxicology Program S.A Elmore, D.V.M., Observer Dynamac Corporation National Toxicology Program Prepared quality assurance audits R.A Herbert, D.V.M., Ph.D. National Toxicology Program S. Brecher, Ph.D., Principal Investigator G.D. Hill, D.V.M., Ph.D. National Toxicology Program K. Karli, D.V.M., Observer National Toxicology Program G. Pearse, B.V.M.&S. National Toxicology Program J.C Peckham, D.V.M., M.S., Ph.D. Experimental Pathology Laboratories, Inc. 3 Constella Group, Inc. Biotechnical Services, Inc. Provided statistical analyses Prepared Technical Report P.W. Crockett, Ph.D., Principal Investigator S.R. Gunnels, M.A., Principal Investigator L.J. Betz, M.S. L.M. Harper, B.S. K.P. McGowan, M.B.A. P.C. Rathman, B.S.E. D.C. Serbus, Ph.D. 4 CONTENTS ABSTRACT . 7 EXPLANATION OF LEVELS OF EVIDENCE OF CARCINOGENIC ACTIVITY . 10 TECHNICAL REPORTS REVIEW SUBCOMMITTEE . 11 SUMMARY OF TECHNICAL REPORTS REVIEW SUBCOMMITTEE COMMENTS . 12 INTRODUCTION . 13 MATERIALS AND METHODS . 19 RESULTS . 25 DISCUSSION AND CONCLUSIONS . 43 REFERENCES . 47 APPENDIX A Summary of Lesions in Male Rats in the 2-Year Inhalation Study of Methyl Isobutyl Ketone . 53 APPENDIX B Summary of Lesions in Female Rats in the 2-Year Inhalation Study of Methyl Isobutyl Ketone . 93 APPENDIX C Summary of Lesions in Male Mice in the 2-Year Inhalation Study of Methyl Isobutyl Ketone . 131 APPENDIX D Summary of Lesions in Female Mice in the 2-Year Inhalation Study of Methyl Isobutyl Ketone . 171 APPENDIX E Genetic Toxicology . 215 APPENDIX F Chemical Characterization and Generation of Chamber Concentrations . 219 APPENDIX G Ingredients, Nutrient Composition, and Contaminant Levels in NTP-2000 Rat and Mouse Ration . 229 APPENDIX H Sentinel Animal Program . 233 Methyl Isobutyl Ketone, NTP TR 538 5 SUMMARY Background Methyl isobutyl ketone has many industrial uses, including as a solvent for paints and lacquers and in dry cleaning. We studied methyl isobutyl ketone to determine if it caused cancer in rats or mice. Methods We exposed groups of 50 male and 50 female rats and mice to air containing concentrations of 450, 900, or 1,800 parts per million (ppm) of methyl isobutyl ketone 6 hours per day for 2 years. Similar groups of 50 animals were exposed to clean air in the same inhalation chambers 6 hours per day as the untreated control groups. Tissues from more than 40 sites were examined for every animal. Results Male rats and female mice exposed to 1,800 ppm methyl isobutyl ketone weighed less than controls, and the death rate of male rats exposed to 1,800 ppm was higher than in the controls. There were no differences in survival or body weights of any other groups exposed to methyl isobutyl ketone. Male rats exposed to methyl isobutyl ketone had tumors of the kidney, increased rates of hyperplasia of the kidney and adrenal gland, and mononuclear cell leukemia. Male and female mice exposed to methyl isobutyl ketone had increased rates of liver tumors. Conclusions We conclude that methyl isobutyl ketone caused cancer of the kidney in male rats and of the liver in male and female mice. Increases in mononuclear cell leukemia in male rats and mesenchymal tumors in the kidney of female rats may also have been related to exposure to methyl isobutyl ketone. 6 Methyl Isobutyl Ketone, NTP TR 538 7 ABSTRACT OHCH 3 H3C CCCCH3 H H METHYL ISOBUTYL KETONE CAS No. 108-10-1 Chemical Formula: C6H12O Molecular Weight: 100.16 Synonyms: Hexanone, hexone, isobutylmethyl ketone, isopropyl-acetone, 4-methyl-2-oxopentane, 4-methyl pentan-2-one, 2-methyl-4-pentanone, 4-methyl-2-pentanone, 2-methyl propyl methyl ketone, MIBK, MIK Methyl isobutyl ketone is used as a denaturant for rub­ those of the chamber controls after weeks 97 and 89, bing alcohol; as a solvent for paints, varnishes, nitrocel­ respectively. lulose, lacquers, and protective coatings; in industrial extraction processes; in dry-cleaning preparations; and In the standard evaluation of the kidney, there were in the synthesis of methyl isobutyl carbinol. Methyl slightly increased incidences of renal tubule adenoma isobutyl ketone was nominated for study by the National and renal tubule adenoma or carcinoma (combined) in Cancer Institute and the United States Environmental males exposed to 900 or 1,800 ppm, and renal tubule Protection Agency because of its widespread use, the carcinoma in males exposed to 1,800 ppm.